knowledge -WSS

knowledge

author：leisure time 2025-10-01 00:49:12 - browse：74574

Steven Pearson — ICER President Steven D. Pearson Craig F. Walker/The Boston Globe

Meetings of the Institute for Clinical and Economic Review don’t usually get one’s heart pumping. But a meeting Thursday at the Massachusetts Institute of Technology may prove to be the exception to that rule.

Patients Rising Now, an advocacy group that says it promotes transparency in health care and that is a fierce opponent of ICER’s, is expected to face off with the self-professed “watchdog of drug pricing” as it reviews three drugs for Duchenne muscular dystrophy.

Dozens of Duchenne patients and their families — many of whom also express concern that ICER’s review could undermine insurers’ already tepid interest in the treatments — are also expected to be in attendance.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Cognito secures funding to test medical device for Alzheimer's

WSS

Do digital therapeutics have a future in medicine?

RaDonda Vaught links Vanderbilt hospital issues to patient death

Vertigo drug brings hope for rare neuron disorder, Niemann

Vertex non

Apple Vision Pro: A first look at health apps on the new VR headset

Woodcock on FDA’s accelerated approval and her next chapter

explore

knowledge

entertainment

Cancer drug shortages should be causing more outrage

Male and female sex labels in research insufficient, scientists say

Jerome Adams on the need for new antivirals for Covid

EPA limits use of carcinogenic gas for sterilizing medical devices

Wildfire smoke exposes gaps in outdoor worker protections

Time to name cancers by genetics, not organ of origin, expert says

United colonoscopy coverage change 'may cost lives,' doctors say

Ebola: Gilead Sciences antiviral shows promise as new treatment

At least 13 dead in Texas as scorching temps continue

What we need to know about Arena Bioworks

hotspot

Time to name cancers by genetics, not organ of origin, expert says

RaDonda Vaught links Vanderbilt hospital issues to patient death

Why depression after traumatic brain injury is distinct

EPA limits use of carcinogenic gas for sterilizing medical devices

Ebola: Gilead Sciences antiviral shows promise as new treatment

Some dementia cases could be undiagnosed liver disease

focus

knowledge

hotspot

hotspot